Código QR (código de barras bidimensional)

Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib

A treat-to-target approach was recently developed to guide systemic treatment for adults with atopic dermatitis (AD). Recommendations outlined criteria for a 3-month initial acceptable treatment target and a 6-month optimal target, evaluated using global assessment of patient-reported disease severi...

Fuld beskrivelse

Na minha lista:
Principais autores: Shawn G. Kwatra, Marjolein de Bruin-Weller, Jonathan I. Silverberg, Peter Lio, Mette Deleuran, Handan Aydin, Brian M. Calimlim, Michael C. Lane, Yingyi Liu, Sarah Ofori, Stephan Weidinger
Format: Artigo
Sprog:Inglês
Udgivet: Medical Journals Sweden 2024-05-01
Serier:Acta Dermato-Venereologica
Fag:
atopic dermatitis
itch
Janus kinase inhibitor
skin clearance
treat-to-target
upadacitinib
Online adgang:https://medicaljournalssweden.se/actadv/article/view/18452
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker